IDRx
IDRx is a clinical-stage biopharmaceutical company that develops oncology-based precision therapies.
$120M Series B+ ·
Led by Blackstone · Source: fundraisingfox.com
Total raised: $242M across 2 sourced rounds
All 2 rounds ↓Acquired by GGlaxoSmithKline on .
Signals
About IDRx
It designs precision combination therapies, which are medicines with engineered drug combinations. These therapies aim to stop key tumor escape mechanisms and prolong response to therapy for gastrointestinal stromal tumors.
IDRx | 1567 days on the record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $120M | fundraisingfox.com | ||
| Series A | $122M | fundraisingfox.com |
Timeline
- Acquired by
GGlaxoSmithKline
- Website created
Founders and team
AB
Alexis Borisy FounderBA
Ben Auspitz FounderGD
George Demetri FounderNL
Nick Lydon FounderRF
Robert Forrester Founder- JAJessica Anderson Chief Development Operations Officer
JC
Jessica Christo Chief Development Operations OfficerSD
Shrenik Desai Vice President, Regulatory AffairsVK
Vic Kadambi Chief Product Development Officer
Investors
AAndreessen Horowitzlead investor
BBlackstonelead investor
CCasdin Capitallead investor
CCommodore Capitallead investor
FForge Life Science Partners
MMerck KGaA, Darmstadt, Germany
NNextech Invest
NNick Lydon
RRA Capital Managementlead investor
RRock Springs Capital
Companies like IDRx
AAkamis Bio$60M Series A · Dec 2024
LLifeMine Therapeutics$75M Series B+ · Aug 2026
CCatalYm$150M Series B+ · Jul 2024
TT-Knife$110M Series B+ · Aug 2021
LLoyalSeries B+ · Mar 2026
BBeeline Medicines$426.3M Series A · Jul 2026
Other companies backed by Blackstone
OOpenEvidence$250M Series B+ · Sep 2026
CCyera$400M Series B+ · Sep 2026
AAutomating software development$200M Series B+ · Sep 2026
EEtched$700M Series B+ · Aug 2026
NNorm AI$120M Series B+ · Jul 2026
TTextQL$17M · Apr 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/idrx (get a free API key).